Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy.
about
Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection.Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?Anti-tumor Activity of Toll-Like Receptor 7 Agonists.
P2860
Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Intravenous administration of ...... ith fractionated radiotherapy.
@en
Intravenous administration of ...... ith fractionated radiotherapy.
@nl
type
label
Intravenous administration of ...... ith fractionated radiotherapy.
@en
Intravenous administration of ...... ith fractionated radiotherapy.
@nl
prefLabel
Intravenous administration of ...... ith fractionated radiotherapy.
@en
Intravenous administration of ...... ith fractionated radiotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Intravenous administration of ...... ith fractionated radiotherapy.
@en
P2093
Eiji Sugaru
Eleanor J Cheadle
Erina Koga-Yamakawa
Gareth Hughes
Hiroki Umehara
Ian J Stratford
Jamie Honeychurch
Ken Eguchi
Masashi Murata
Philip J Jewsbury
P2860
P304
17035-17046
P356
10.18632/ONCOTARGET.7928
P407
P577
2016-03-05T00:00:00Z